Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Mar
4
2020
The 2019 Honig Act Means New Obligations for New Jersey Employers Around Cannabis at Work Wilson Elser Moskowitz Edelman & Dicker LLP
Mar
4
2020
Proposed Class Action Urges Court Not to Dismiss Suit Against Florida CBD Manufacturer Keller and Heckman LLP
Mar
3
2020
FDA Finalizes Clinical Laboratory Guidance Documents For In Vitro Diagnostic Tests Barnes & Thornburg LLP
Mar
3
2020
PFAS Update: EPA Begins Process of Developing Drinking Water Limits for PFOS and PFOA Greenberg Traurig, LLP
Mar
3
2020
EFSA Publishes Draft Scientific Opinion on PFASs in Food Keller and Heckman LLP
Mar
3
2020
Disposables are Making Vaping Harder to Detect Among Teens Stark & Stark
Mar
3
2020
EPA Extends Comment Period for Proposed Registration Decision for New Nanosilver Product Bergeson & Campbell, P.C.
Mar
2
2020
FDA Launches Limited Pilot Program For Interactive 510(K) Application Barnes & Thornburg LLP
Mar
2
2020
FIFRA Stakeholders: How to Respond to an Enforcement Action or Inquiry Bergeson & Campbell, P.C.
Mar
2
2020
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums Foley & Lardner LLP
Mar
2
2020
Germany Publishes English Translation of TRGS 527: Activities with Nanomaterials Bergeson & Campbell, P.C.
Mar
2
2020
Florida Medical Marijuana Users May Soon Become Protected Class Under State Employment Laws
Mar
2
2020
FDA Extends Comment Period on Proposed Rule for Laboratory Accreditation Program Keller and Heckman LLP
Feb
28
2020
340B In The Spotlight – CMS 340B Acquisition Cost Survey Proposal & President’s Budget Polsinelli PC
Feb
28
2020
DEA Initiates Rule making to Waive Separate Registration for Mobile NTP McDermott Will & Emery
Feb
28
2020
Biobased Plastics and the Sustainability Puzzle* Keller and Heckman LLP
Feb
28
2020
ASTM International Biotechnology Task Group Seeking Members Bergeson & Campbell, P.C.
Feb
28
2020
FSANZ Releases 2019 Food Recall Statistics Keller and Heckman LLP
Feb
28
2020
FDA Upgrades Its Database Of Licensed Biological Products & Amends It's Definition Bergeson & Campbell, P.C.
Feb
28
2020
Federal Circuit Changes the Game for Selling Single-API Drugs to the Government Sheppard, Mullin, Richter & Hampton LLP
Feb
28
2020
Proposed Supplemental SNUR Would Remove Exemption for LCPFAC Chemical Substances Used as Surface Coatings on Articles Bergeson & Campbell, P.C.
Feb
28
2020
False Claims Act Whistleblower Recovers More than $2.5M in Damages in False Claims Act Whistleblower Retaliation Case Zuckerman Law
Feb
28
2020
FTC, FDA Team Up Against Anticompetitive Tactics in Biological Product Industry MoginRubin
Feb
27
2020
FDA Permanently Exempts Type III DMFs for Drug Packaging Materials from eCTD Format Requirement Keller and Heckman LLP
Feb
27
2020
Ethical Veganism And The Broadening Range Of Philosophical Beliefs Protected By UK Discrimination Laws McDermott Will & Emery
Feb
27
2020
FDA Data Shows an Increase in Food Facility Violations for Failing to Develop a Foreign Supplier Verification Program Keller and Heckman LLP
Feb
27
2020
Antitrust Byte: FDA and FTC Join Forces to Promote Biosimilars Epstein Becker & Green, P.C.
Feb
26
2020
FDA Issues More Guidance On Intentional Adulteration Of Food Rule Barnes & Thornburg LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins